![Noah Berkowitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Noah Berkowitz
Chief Executive Officer at
HaptoGuard, Inc.
Net worth: 2 M $ as of 2026-08-30
Profile
Noah Berkowitz is the founder of Physician's Choice, Inc. Currently, Dr. Berkowitz is President & Chief Executive Officer at HaptoGuard, Inc. Formerly, Dr. Berkowitz was Chief Medical Officer at Arvinas, Inc. from 2024 to 2026, President, Chief Executive Officer & Secretary at Synvista Therapeutics, Inc. from 2006 to 2012, Director at Poseida Therapeutics, Inc., Vice President-Clinical Development at IMPATH, Inc., Consultant at Predix Pharmaceuticals, Inc., Consultant at Teva Pharmaceuticals USA, Inc., and Senior Vice President & Head-Hematology at Bristol Myers Squibb Co. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARVINAS, INC. 0.29% | 2026-05-10 | 191,395 ( 0.29% ) | 2 M $ | 2026-08-30 |
Noah Berkowitz active positions
| Companies | Position | Start |
|---|---|---|
HaptoGuard, Inc.
 HaptoGuard, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Chief Executive Officer | - |
Former positions of Noah Berkowitz
| Companies | Position | End |
|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | 2026-07-02 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| POSEIDA THERAPEUTICS, INC. | Director/Board Member | - |
IMPATH, Inc.
 IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Chief Tech/Sci/R&D Officer | - |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Corporate Officer/Principal | - |
Training of Noah Berkowitz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Synvista Therapeutics, Inc.
 Synvista Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases of cardiovascular aging and diabetes complications | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
IMPATH, Inc.
IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Health Services |
HaptoGuard, Inc.
HaptoGuard, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physician's Choice, Inc.
 Physician's Choice, Inc. Internet Software/ServicesTechnology Services Provides postclinical, premarketing, cost-benefit analysis to biotech companies | Technology Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
- Stock Market
- Insiders
- Noah Berkowitz
